Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: Myfortic for the Treatment of Non-infectious Intermediate Uveitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Myfortic for non-infectious intermediate uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: STZ eyetrial | Conditions: Uveitis, Intermediate | Phase 3 | Status: COMPLETED